東北大学大学院医学系研究科・医学部

STAFF

Professor

• Aoyagi, TetsujiProfessor. 青柳 哲史 教授 (兼任)
  

Other Faculty / Staff

• Baba, Hiroaki

  Lect. 馬場 啓聡 講師

CONTACT

OUTLINE

The threat of emerging infectious diseases, such as coronavirus disease 2019 (COVID-19), the risks of healthcare-associated infections, and the concern about antimicrobial resistant organisms have been increasing worldwide. The Department of Comprehensive Infection operates together with the Department of Clinical Microbiology and Infection, and conducts research and development from basic research to clinical application in the areas of infectious diseases diagnostics and treatment, infection control and prevention, and clinical microbiology and immunology. Specifically, we will focus on basic and clinical research in the development of new anti-microbial agents and vaccines, establishment of new diagnostic methods for infectious diseases, understanding of host-pathogens interaction, and mechanisms and molecular epidemiology of antimicrobial resistance, antimicrobial stewardship and therapy, and development of infection prevention strategies and control measures. By establishing an integrated basic and clinical approach to infectious diseases and infection control, we educate students and researchers in the Departments of Medicine and Health Sciences, and train specialists with comprehensive skills in the diagnosis, treatment, and prevention of infectious diseases and infection control. We also conduct clinical management and infection control for antimicrobial resistance at Tohoku University Hospital and promote diagnostic stewardship with rapid molecular tests and an antimicrobial stewardship program. Networks are vitally important in the crisis management of infectious diseases, and, as part of a group, we are responsible for managing a regional infection control network.

COVID-19をはじめとする国境を越えて新興・再興感染症の脅威が高まってきており、感染症は世界中の医療関連施設、地域社会全体の危機と認識され、感染症診療および感染症対策はますます重要になってきております。感染症は、微生物が人から人あるいは物から人に伝播するという特徴があるため、個人や病棟・医療施設を超えて、さらには地域全体に感染症が伝播・拡大し、危機的な状況を引き起こす可能性があります。総合感染症学分野は、保健学　感染病態学分野と教室を共に運営し、臨床感染症、感染制御学、感染症疫学、臨床微生物学の領域において基礎的研究から臨床応用を目指した研究開発を行います。具体的には、新規抗微生物薬やワクチン開発、感染症新規診断法の確立、重症感染症の病態解明と治療法の開発、薬剤耐性菌の耐性メカニズムと分子疫学、抗菌薬適正使用と感染症治療、新規感染制御策の開発などに取り組みを行います。このように基礎―臨床一体化した感染症学を確立することで医学科・保健学科の学生教育や研究者の育成、感染症に関する診断・治療・予防に関する総合的な対応能力を有する専門的人材の育成をおこなっています。また、総合感染症科では、感染管理室と協力して、感染症診療、感染制御、感染症疫学などに関する専門的資格を有する教員が、感染症の診断・治療・予防に関する総合的マネジメント業務を行い、東北大学病院ならびに地域の医療関連施設での感染症対策を実践しております。

• 

  
  教室運営ビジョン

• 

  
  

ARTICLE

Aoyagi T, et al. Successful Treatment of Five Critically Ill Coronavirus Disease 2019 Patients Using Combination Therapy With Etoposide and Corticosteroids. Front Med (Lausanne). 8:718641, 2021. doi: 10.3389/fmed.2021.718641. eCollection 2021.

Kanamori H, Weber DJ, Rutala WA. The role of the healthcare surface environment in SARS-CoV-2 transmission and potential control measures. Clin Infect Dis. 72(11):2052-2061, 2021. doi: 10.1093/cid/ciaa1467.

Niitsuma-Sugaya I, et al. Disseminated Gonococcal Infection in a Patient with Paroxysmal Nocturnal Hemoglobinuria Receiving Eculizumab. Lancet Infect Dis. 21(5):741, 2021. doi: 10.1016/S1473-3099(20)30930-0.

Oshima K, et al. Pulmonary infection caused by Mycobacterium marinum in a patient with anorexia nervosa. ERJ Open Res. 2021;7(1):00782-2020. doi: 10.1183/23120541.00782-2020.

Baba H, Kanamori H. Are Reservoirs and Transmission Routes the Same or Different Between O157 and Non-O157 Shiga Toxin-Producing Escherichia coli? Clin Infect Dis. 71(5):1352-1353, 2020. doi: 10.1093/cid/ciz1111.